Condition: Non-Small Cell Lung Cancer · NSCLC · PDAC - Pancreatic Ductal Adenocarcinoma · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A first in human study to evaluate the safety and preliminary antitumor activity of BBO-11818, a pan-KRAS inhibitor, in subjects with locally advanced unresectable or metastatic KRAS mutant solid tumors.
This description comes directly from the study's public registry record.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · (650) 405-4770 · tbbo11818-101ct.gov@bbotx.com
Always discuss trial participation with your own doctor first.
| The Angeles Clinic and Research Institute - West Los Angeles Office | Los Angeles, California, United States | Recruiting |
| University of California Davis | Sacramento, California, United States | Recruiting |
| University of California San Diego Moores Cancer Center | San Diego, California, United States | Recruiting |
| University of California San Francisco Helen Diller Family Comprehensive Cancer Center | San Francisco, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| OSF Healthcare Cancer Institute | Peoria, Illinois, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| NYU Langone Health | New York, New York, United States | Recruiting |
| Columbia University Irving Medical Center | New York, New York, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
| Sarah Cannon Research Institute at Mary Crowley | Dallas, Texas, United States | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06917079